# The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024, Regulation 5: Insertion of new regulation 3B


After regulation 3A (sponsor’s responsibility for the investigator’s brochure) insert—
“Investigator in a clinical trial
3B The investigator, in relation to a clinical trial, shall be a health care professional who is appropriately trained to undertake that role in a clinical trial.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348267167/regulation/5 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-regulations-2024/regulation-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.